DUAL CIRCULATORY SUPPORT WITH ECMO AND MCS DEVICES IS ASSOCIATED WITH SHORTER HOSPITAL STAY WITHOUT COMPROMISING HEART TRANSPLANT SURVIVAL

Authors

Tawanda Zinyandu, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, Connecticut, USA.
Abhinav Aggarwal, Department of Internal Medicine, Yale New Haven Health, Bridgeport Hospital, Bridgeport, CT 06605, USA.
Ashraf Ahmed, Yale New Haven Health - Bridgeport Hospital Department of Internal Medicine, Bridgeport, CT 06610, United States.Follow
Isaac Opoku MD, Yale New Haven Health/Bridgeport Hospital
Didien Meyahnwi MD, Yale New Haven Health/Bridgeport HospitalFollow
Yussuf Isaka MD, Yale New Haven Health/Bridgeport Hospital
Stuart Zarich, Department of Cardiovascular Medicine, Bridgeport Hospital/Yale University Program, Bridgeport, CT, USA.
Carlos Davila, Division of Cardiovascular Diseases, Bridgeport Hospital, Yale New Haven Health, Bridgeport, Connecticut, USA.

Document Type

Conference Proceeding

Abstract

• ECMO is commonly used as a bridge to heart transplantation in critically ill patients.
• Additional MCS devices (e.g., Impella, IABP) may be used alongside ECMO to enhance cardiac output.
• The effect of dual circulatory support vs. ECMO alone on post-transplant survival is unclear especially after 2018, when the heart allocation system was revised to reduce waitlist times for MCS patients.

Publication Date

Spring 2025

Comments

Presented at American College of Cardiology, 2025

Recommended Citation

Zinyandu, Tawanda; Aggarwal, Abhinav; Ahmed, Ashraf; Opoku, Isaac MD; Meyahnwi, Didien MD; Isaka, Yussuf MD; Zarich, Stuart; and Davila, Carlos, "DUAL CIRCULATORY SUPPORT WITH ECMO AND MCS DEVICES IS ASSOCIATED WITH SHORTER HOSPITAL STAY WITHOUT COMPROMISING HEART TRANSPLANT SURVIVAL" (2025). Posters. 59.
https://scholar.bridgeporthospital.org/poster_presentations/59